Accueil・Liste d'Actions・Boston Scientific Corp.

Boston Scientific Corp.

Fermé

SecteurSoins de santé

47.8 1.9

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

47.77

Max

48.05

Chiffres clés
By Trading Economics
Revenu	-437M 904M
Ventes	239M 5.4B
P/E Moyenne du Secteur	18.941 56.659
BPA	0.86
Marge bénéficiaire	16.612
Employés	59,000
EBITDA	-214M 1.4B

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+27.62% upside

Dividendes
By Acuity
Prochains Résultats	28 oct. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	2.4B 70B
Ouverture précédente	45.9
Clôture précédente	47.8

Sentiment de l'Actualité

By Acuity

57%

43%

262 / 339 Classement par Healthcare

Boston Scientific Corp. Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

4 sept. 2026, 23:05 UTC

Boston Scientific Corp shares are lower in after-market trading amid mixed economic signals, including a slight rise in unemployment and increased Treasury yields.

3 sept. 2026, 20:02 UTC

News

Macro Event

Boston Scientific Corp is under scrutiny after notifying customers about the removal of Infinion CX leads linked to serious injuries, contributing to a stock decline.

2 sept. 2026, 23:21 UTC

Boston Scientific shares are higher in after-market trading, despite no specific news. Weaker job growth data may influence Federal Reserve interest rate expectations.

1 sept. 2026, 23:06 UTC

Boston Scientific Corp shares are lower in after-market hours, fluctuating within a narrow range and remaining below the 20-day moving average. No specific news was identified.

31 août 2026, 23:06 UTC

Boston Scientific shares are higher in after-market trading, with no specific news identified. Broader market sentiment reflects heightened expectations for a Federal Reserve rate hike.

28 août 2026, 23:06 UTC

Boston Scientific Corp. shares traded roughly flat in after-market hours, with no specific news identified and a slight cumulative return of 0.01%.

27 août 2026, 23:01 UTC

Boston Scientific Corp shares are higher in after-market hours. No specific company news was identified to explain the movement, amid broader labor market data.

26 août 2026, 23:01 UTC

News

Boston Scientific shares rise in after-market hours, supported by positive market sentiment despite recent operational challenges from a cybersecurity incident affecting IT systems.

25 août 2026, 23:01 UTC

Boston Scientific Corp shares are higher in after-market trading, amid a broader market reaction to a significant drop in crude oil prices.

24 août 2026, 20:01 UTC

News

Boston Scientific Corp shares are lower amid broader market declines linked to geopolitical tensions and concerns over oil supply disruptions affecting investor sentiment.

22 août 2026, 00:01 UTC

Boston Scientific Corp is trading higher in after-market hours, reflecting broader market gains despite no specific company news driving the movement.

21 août 2026, 23:01 UTC

Boston Scientific shares are higher in after-market trading, positioned above their 20-day moving average and near the upper end of their one-month range.

20 août 2026, 22:51 UTC

Boston Scientific shares are higher in after-market trading, reflecting a gain since Thursday's close and remaining above the 20-day moving average.

19 août 2026, 20:02 UTC

Boston Scientific shares are higher as the Health Care Equipment sector shows strong momentum. The stock is trading with unusually high volume today.

18 août 2026, 23:06 UTC

Boston Scientific Corp shares are trading higher in after-market hours, remaining above their 20-day moving average amid broader market pressures from rising bond yields.

17 août 2026, 23:16 UTC

Boston Scientific shares are higher in after-market hours, showing a slight gain since Monday's close. The stock remains stable near its one-month range.

15 août 2026, 00:01 UTC

Boston Scientific Corp shares are higher in after-market hours, continuing a trend of six consecutive sessions of gains. No specific news was identified for this movement.

14 août 2026, 23:01 UTC

Boston Scientific Corp shares are higher in after-market trading, continuing a trend of six consecutive sessions finishing higher. No specific news was identified.

13 août 2026, 23:01 UTC

Social Media

Boston Scientific shares are higher in after-market trading, buoyed by social media discussions of the CEO's $9 million stock purchase amid a significant year-to-date decline.

12 août 2026, 23:06 UTC

Boston Scientific Corp shares are modestly higher in after-market trading. The stock remains significantly above its 20-day moving average.

11 août 2026, 23:41 UTC

Boston Scientific Corp shares are lower in after-market trading, showing unusual volatility and reflecting a broader trend of weakness since Tuesday's close.

10 août 2026, 23:06 UTC

Boston Scientific shares are trading higher in after-market hours, amid mixed market sentiment influenced by geopolitical tensions, particularly concerning the Strait of Hormuz.

8 août 2026, 00:01 UTC

Boston Scientific Corp shares are higher in after-market trading, reflecting gains since Friday's close and remaining above their 20-day moving average.

7 août 2026, 23:21 UTC

Boston Scientific shares are higher in after-market hours following a Labor Department report showing a decline in non-farm payroll employment, reducing interest rate hike expectations.

6 août 2026, 23:01 UTC

Boston Scientific Corp shares are higher during after-market hours, reflecting a generally strong performance backdrop amid resilient labor market data.

5 août 2026, 23:02 UTC

Social Media

News

Boston Scientific Corp shares rose in after-market trading following CEO Mahoney's purchase of 186,240 shares at an average price of $48.33.

4 août 2026, 19:36 UTC

News

Boston Scientific shares are higher, supported by strong organic revenue growth and rising free cash flow margin, despite recent economic data pressures.

3 août 2026, 23:01 UTC

Boston Scientific Corp shares are higher in after-market hours, reflecting positive momentum. Broader economic news shows increased growth in the manufacturing sector.

31 juil. 2026, 22:52 UTC

Boston Scientific Corp shares are higher in after-market trading, reflecting positive market sentiment from strong earnings by major tech companies.

30 juil. 2026, 23:51 UTC

News

Boston Scientific shares are higher in after-market trading following UBS's Buy rating and a price target adjustment to $67 amid Penumbra's results.

Comparaison

Variation de prix

Boston Scientific Corp. prévision

Objectif de Prix

By TipRanks

27.62% hausse

Prévisions sur 12 Mois

Moyen 61 USD 27.62%

Haut 85 USD

Bas 50 USD

Basé sur 22 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

22 ratings

Achat

Maintien

Vente

Basé sur 22 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

262 / 339Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Boston Scientific Corp.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.